Skip to main content

Table 1 Baseline characteristics of the two groups

From: Effect of preoperative nutritional support in malnourished patients with pancreatobiliary cancer: a quasi-experimental study

Factors

PNSP

Well-nourished

p

(n = 45)

(n = 45)

 

n (%) or median (min─max)

 

Age

>75 years

7 (15.6%)

4 (8.9%)

0.334*

Sex

Male

30 (66.7)

29 (64.4)

0.824*

Female

15 (33.3)

16 (35.6)

 

ECOG

0

28 (62.2)

37 (82.2)

0.034

1

17 (37.8)

8 (17.8)

 

ASA score

1

4 (8.9)

10 (22.2)

0.071

2

36 (80.0)

34 (75.6)

 

3

5 (11.1)

1 (2.2)

 

Diagnosis

Bile duct cancer

28 (62.2)

22 (48.9)

0.443#

Gallbladder cancer

2 (4.4)

2 (4.4)

 

Pancreatic cancer

15 (33.3)

20 (44.4)

 

Others

0 (0.0)

1 (2.2)

 

External biliary drain

No

31 (68.9)

37 (82.2)

0.220#

Yes

14 (31.1)

8 (17.8)

 

HbA1c

≥ 6.5%

15 (33.3)

16 (35.6)

0.999#

CA 19-9

> 37.0U/mL

31 (70.5)

15 (34.9)

0.001#

CEA

> 5.0ng/mL

12 (26.7)

7 (17.1)

0.311#

T stage

1 or 2

18 (40.0)

17 (37.8)

0.999#

3 or 4

27 (60.0)

28 (62.2)

 

LN metastasis

No

21 (47.7)

18 (40.0)

0.525#

Yes

23 (52.3)

27 (60.0)

 

Differentiation

Well or Moderate

26 (78.8)

22 (50.0)

0.047#

Poor

7 (21.2)

18 (45.0)

 

Cancer Stage

1 or 2

40 (88.9)

39 (86.7)

0.999

(AJCC 8th)

3 or 4

5 (11.1)

6 (13.3)

 

Type of surgery

PD/PPPD

30 (66.7)

27 (60.0)

0.377#

HPD

4 (8.9)

1 (2.2)

 

Hepatectomy + BDR

8 (17.8)

11 (24.4)

 

Distal panceatectomy

3 (6.7)

6 (13.3)

 
  1. PNSP preoperative nutritional support program, ECOG Eastern Cooperative Oncology Group, ASA american society of anesthesiologists, HbA1c hemoglobin A1c, CA 19-9 Carbohydrate Antigen 19-9, CEA carcinoembryonic antigen, LN Lymph node, PD pancreatoduodenectomy, PPPD pylorus preserving pancreatoduodenectomy, HPD hepaticopancreatoduodenectomy, BDR bile duct resection
  2. *chi-square test, #Fisher’s exact test